Why the study?
Managing acute pancreatitis secondary to hypertriglyceridemia is challenging, particularly during pregnancy, requiring therapeutic options when plasmapheresis and gene therapy are unavailable.
Intravenous insulin combined with lipid-lowering drugs may serve as a viable management strategy for acute pancreatitis secondary to hypertriglyceridemia during pregnancy in resource-limited settings.
Key Clinical Message: Managing acute pancreatitis secondary to hypertriglyceridemia in pregnancy is challenging. The use of intravenous insulin along with lipid lowering drugs can be an option in settings where plasmapharesis and gene therapy are unavailable. Abstract: Acute pancreatitis secondary to hypertriglyceridemia is rare but various studies have highlighted it as the third most common cause following gallstones and alcohol consumption. Managing acute pancreatitis is always challenging; even more challenging during pregnancy. We present a case of a 31-year- old female with a history of recurrent pancreatitis secondary to hypertriglyceridemia with a current episode of acute pancreatitis at 21 weeks of gestation.
No takes yet. Share an insight, caveat, or question.
Nazeef et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: